INmune Bio, Inc. (NASDAQ:INMB) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants David Moss - Co-Founder & Chief Financial Officer RJ Tesi - Chief Executive Officer and Co-Founder Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Mayank Mamtani - B. Riley Securities Jason McCarthy - Maxim Group Sung Nam - BTIG Michael Irwin - Univest Securities Daniel Carlson - Tailwinds Research Operator Greetings and welcome to the INmune Bio First Quarter 2021 Earnings Call. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 INMUNE BIO INC. (Exact name of registrant as specified in its charter) Nevada 47-5205835 (State of incorporation) (I.R.S. Employer Identification No.) David Moss 1200 Prospect Street, Suite ...

INmune Bio, Inc. (NASDAQ:INMB) Q4 2020 Earnings Conference Call March 4, 2021 4:30 PM ET Company Participants RJ Tesi - Co-Founder and CEO David Moss - Co-Founder and CFO Conference Call Participants Tom Shrader - BTIG Jonathan Aschoff - ROTH Capital Partners Daniel Carlson - Tailwinds Research Brett Conrad - Longboard Capital Michael Irwin - Univest Security Operator Greetings, and welcome to the INmune Bio Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2020 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-38793 INMUNE BIO INC. (Exact name of registrant as specified in its charter) Nevada 47-5205835 (State or other jurisdiction of inco ...

INmune Bio, Inc. (NASDAQ:INMB) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants RJ Tesi - Co-Founder and CEO David Moss - Co-Founder and CFO Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Julian Harrison - BTIG Jason McCarthy - Maxim Group Michael Irwin - Univest Security Operator Greetings, and welcome to the INmune Bio Third Quarter 2020 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. A transcript will follow ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 INMUNE BIO INC. (Exact name of registrant as specified in its charter) Nevada 47-5205835 (State of incorporation) (I.R.S. Employer Identification No.) David Moss 1200 Prospect Street, S ...

IViunine Bio HARNESSING THE POWER OF THE INNATE IMMUNE SYSTEM Modulating an Innate Immune Response Against Diseases INMB CORPORATE PRESENTATION Aug 2020 FORWARD LOOKING STATEMENTS This presentation contains "forward-looking statements" Forward-looking statements reflect our current view about future events. When used in this presentation, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our ma ...

INmune Bio Inc. (NASDAQ:INMB) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants RJ Tesi - Co-Founder & Chief Executive Officer David Moss - Co-Founder & Chief Financial Officer Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Naureen Quibria - Maxim Group Arthur He - H.C. Wainwright Operator Greetings and welcome to the INmune Bio Second Quarter 2020 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. A transcript will f ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 INMUNE BIO INC. (Exact name of registrant as specified in its charter) Nevada 47-5205835 (State of incorporation) (I.R.S. Employer Identification No.) David Moss 1200 Prospect Street, Suite 525 La Jolla, CA 92037 (Address of principal executive of ice) (Zip code) FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2020 OR ☐ TRANSITION REPO ...

INmune Bio, Inc. (NASDAQ:INMB) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants RJ Tesi - Co-Founder and Chief Executive Officer David Moss - Co-Founder and Chief Financial Officer Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Jason McCarthy - Maxim Michael Erwin - Universe Securities Arthur He - H.C. Wainwright Operator Greetings and welcome to INmune Bio’s First Quarter 2020 Earnings Call. At this time all lines have been placed on a listen only mode a ...